PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

De S et al. – Eculizumab, a monoclonal humanized anti–C5 antibody, has recently been shown to be effective and well–tolerated in patients with paroxysmal nocturnal hemoglobinuria by preventing complement–mediated lysis of affected erythrocytes. Treatment of the patient with eculizumab is supported by recent reports on its successful use in two (pediatric and adult) patients with complement–based aHUS.


   

Today in Pediatrics...keeping you current

Oral Ibuprofen and Ductus Arteriosus Closure in Full-Term Neonates: A Prospective Case-Control Study
Pediatric Cardiology, 10/30/09

Use of over-the-counter cough and cold medications in children
Canadian Family Physician, 11/13/09

Anti-inflammatory drug therapy in asthma
Paediatric Respiratory Reviews, 11/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address